1478-7547

Cost Effectiveness and Resource Allocation

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 649 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact649 DOIs
2

Add abstracts to 478 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact478 DOIs
3

Add license metadata to 258 records

License metadata tells indexers and readers how each article may be reused.

Medium impact258 DOIs

DOIs for this ISSN

Showing the top 5 of 955 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 — (10.1186/1478-7547-4-14)
Abstract References ORCID License
262.53 421
2 Generalized cost-effectiveness analysis for national-level p… (10.1186/1478-7547-1-8)
Abstract ORCID License
195.80 407
3 — (10.1186/1478-7547-4-20)
Abstract References ORCID License
194.94 88
4 The economic burden of inpatient paediatric care: household… (10.1186/1478-7547-7-3)
Abstract References ORCID License
193.95 86
5 Combining multicriteria decision analysis, ethics and health… (10.1186/1478-7547-8-4)
Abstract References ORCID License
190.31 79
6 Can economic evaluation in telemedicine be trusted? A system… (10.1186/1478-7547-7-18)
Abstract References ORCID License
189.21 77
7 The economic impact of chronic fatigue syndrome in Georgia:… (10.1186/1478-7547-9-1)
Abstract References ORCID License
183.88 68
8 Cost effectiveness of community-based therapeutic care for c… (10.1186/1478-7547-7-2)
Abstract References ORCID License
178.53 60
9 Programme costs in the economic evaluation of health interve… (10.1186/1478-7547-1-1)
Abstract ORCID License
177.41 231
10 Dynamic effects of smoking cessation on disease incidence, m… (10.1186/1478-7547-6-1)
Abstract References ORCID License
177.09 58
11 Adding a quadrivalent human papillomavirus vaccine to the UK… (10.1186/1478-7547-6-4)
Abstract References ORCID License
175.59 56
12 Consolidated Health Economic Evaluation Reporting Standards… (10.1186/1478-7547-11-6)
Abstract ORCID License
174.17 209
13 The economic impact of chronic fatigue syndrome (10.1186/1478-7547-2-4)
Abstract ORCID License
171.92 195
14 Societal costs of air pollution-related health hazards: A re… (10.1186/1478-7547-6-19)
Abstract References ORCID License
171.60 51
15 Generalized cost-effectiveness analysis of a package of inte… (10.1186/1478-7547-7-10)
Abstract References ORCID License
170.76 50
16 Cost analyses of obesity in Canada: scope, quality, and impl… (10.1186/1478-7547-11-3)
Abstract References ORCID License
169.02 48
17 Cost-utility of Intravenous Immunoglobulin (IVIG) compared w… (10.1186/1478-7547-8-14)
Abstract References ORCID License
168.12 47
18 The economics of primary prevention of cardiovascular diseas… (10.1186/1478-7547-5-5)
Abstract References ORCID License
165.32 44
19 People's willingness to pay for health insurance in rural Vi… (10.1186/1478-7547-6-16)
Abstract References ORCID License
164.35 43
20 Health care priority setting: principles, practice and chall… (10.1186/1478-7547-2-3)
Abstract ORCID License
162.55 146
21 Formulas for estimating the costs averted by sexually transm… (10.1186/1478-7547-6-10)
Abstract References ORCID License
162.32 41
22 Cost-effectiveness analysis of the available strategies for… (10.1186/1478-7547-7-5)
Abstract References ORCID License
161.28 40
23 Guidance on priority setting in health care (GPS-Health): th… (10.1186/1478-7547-12-18)
Abstract ORCID License
160.96 139
24 Cost-effectiveness of a nurse-led telemonitoring interventio… (10.1186/1478-7547-5-10)
Abstract References ORCID License
160.21 39
25 Giving tranexamic acid to reduce surgical bleeding in sub-Sa… (10.1186/1478-7547-8-1)
Abstract References ORCID License
160.21 39
26 The health related quality of life of people living with HIV… (10.1186/1478-7547-8-5)
Abstract References ORCID License
160.21 39
27 Econometric estimation of country-specific hospital costs (10.1186/1478-7547-1-3)
Abstract ORCID License
158.29 128
28 Burden of disease and costs of aneurysmal subarachnoid haemo… (10.1186/1478-7547-8-6)
Abstract ORCID License
157.27 124
29 The cost-effectiveness of preventing mother-to-child transmi… (10.1186/1478-7547-9-3)
Abstract References ORCID License
156.82 36
30 A cost-effectiveness analysis of a 10-valent pneumococcal co… (10.1186/1478-7547-11-21)
Abstract References ORCID License
154.41 34
31 Methods for analyzing cost effectiveness data from cluster r… (10.1186/1478-7547-5-12)
Abstract References ORCID License
154.41 34
32 Changes in costs and effects after the implementation of dis… (10.1186/1478-7547-12-17)
Abstract References ORCID License
153.15 33
33 A cost function for HIV prevention services: is there a 'u'… (10.1186/1478-7547-5-13)
Abstract References ORCID License
151.85 32
34 Estimating average inpatient and outpatient costs and childh… (10.1186/1478-7547-7-16)
Abstract References ORCID License
151.85 32
35 — (10.1186/1478-7547-4-13)
Abstract References ORCID License
150.51 31
36 — (10.1186/1478-7547-4-19)
Abstract References ORCID License
150.51 31
37 — (10.1186/1478-7547-5-2)
Abstract References ORCID License
150.51 31
38 WTP for a QALY and health states: More money for severer hea… (10.1186/1478-7547-11-22)
Abstract ORCID License
150.32 100
39 Cost-utility analysis of infliximab and adalimumab for refra… (10.1186/1478-7547-7-20)
Abstract References ORCID License
149.14 30
40 Methodologies used in cost-effectiveness models for evaluati… (10.1186/1478-7547-10-1)
Abstract References ORCID License
147.71 29
41 Cost-effectiveness of ranibizumab for neovascular age-relate… (10.1186/1478-7547-6-12)
Abstract References ORCID License
147.71 29
42 Quantifying the economic burden of malaria in Nigeria using… (10.1186/1478-7547-5-6)
Abstract References ORCID License
146.24 28
43 Could CT screening for lung cancer ever be cost effective in… (10.1186/1478-7547-6-5)
Abstract References ORCID License
146.24 28
44 Cost-effectiveness of a pressure ulcer quality collaborative (10.1186/1478-7547-8-11)
Abstract References ORCID License
144.72 27
45 Health research priority setting in selected high income cou… (10.1186/1478-7547-12-23)
Abstract ORCID License
143.14 80
46 — (10.1186/1478-7547-5-3)
Abstract References ORCID License
143.14 26
47 Are multidisciplinary teams in secondary care cost-effective… (10.1186/1478-7547-11-7)
Abstract ORCID License
141.06 75
48 Do economic evaluation studies inform effective healthcare r… (10.1186/1478-7547-12-15)
Abstract References ORCID License
139.79 24
49 Cost analysis of an integrated disease surveillance and resp… (10.1186/1478-7547-7-1)
Abstract References ORCID License
139.79 24
50 Ownership and technical efficiency of hospitals: evidence fr… (10.1186/1478-7547-12-9)
Abstract ORCID License
139.30 71